
Unraveling the Mysteries of Cystathioninuria: Genetic Testing and Beyond
Explore the genetic basis of cystathioninuria, benefits of genetic testing for diagnosis & treatment, and implications for affected individuals & families.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore the genetic basis of cystathioninuria, benefits of genetic testing for diagnosis & treatment, and implications for affected individuals & families.

Discover the benefits of genetic testing for diagnosing autosomal dominant nonsyndromic sensorineural deafness 39 with dentinogenesis imperfecta 1 (ADNSHL39-DDI1).

Discover the role of genetic testing in understanding and diagnosing Autosomal Recessive Deafness, specifically DFNB12, and learn how it influences family planning and treatment…

Discover the role of genetic testing in diagnosing autosomal recessive deafness 36 (DFNB36), carrier screening, prenatal testing, and advancing research for better treatments.

Discover how genetic testing aids in diagnosing Dejerine-Sottas neuropathy, identifying carriers, guiding treatment, and understanding this rare genetic disorder.

Discover how genetic testing for deuteranomaly, the most common form of color blindness, can help diagnose the condition, inform treatment options, and assess inheritance risks.

Discover the role of genetic testing in diagnosing and managing camptothecin-resistant DNA topoisomerase I, enabling personalized treatment and early intervention.

Discover the role of genetic testing in diagnosing DNA topoisomerase II resistance to amsacrine inhibition, improving treatment strategies, and patient outcomes.